With the progressive implementation of guidance-supported treatments for coronary heart disease, such as percutaneous coronary intervention (PCI), antiplatelet therapy, statins, and angiotensin converting enzyme (ACE) inhibitors, the overall prognosis for CHD has improved significantly over time. Here, ACE is linked to coronary artery disorder.